Search Results
50 items found for "Orion Biotechnology"
Posts (24)
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting His presentations will describe Orion’s drug discovery platform, one of the fastest drug discovery solutions Hartley will also present new data on Orion’s CCR2 antagonist, OB-004, demonstrating the ability of this
- Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...
July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional
Other Pages (26)
- 23-03 Dr GPCR Newsletter
Oliver Hartley, Associate Professor at the University of Geneva and VP of Drug Discovery at Orion Biotechnology Therapeutics , Design Pharmaceuticals , Montana Molecular as well as the newest addition to our Ecosystem Orion Biotechnology for supporting Dr. In case you missed it, our friends at Orion Biotechnology published their first news in the Ecosystem
- 23-02 Dr GPCR Newsletter
Therapeutics , Design Pharmaceuticals , Montana Molecular as well as the newest addition to our Ecosystem Orion Biotechnology for supporting Dr. In case you missed it, our friends at Orion Biotechnology published their first news in the Ecosystem
- 23-01 Dr. GPCR Newsletter
Therapeutics , Design Pharmaceuticals , Montana Molecular as well as the newest addition to our Ecosystem Orion Biotechnology for supporting Dr.